Literature DB >> 32303904

Rs9939609 polymorphism of the fat mass and obesity-associated (FTO) gene and metabolic syndrome susceptibility in the Chinese population: a meta-analysis.

Dong Wang1, Zhihong Wu2, Jun Zhou3, Xiaotian Zhang4.   

Abstract

PURPOSE: The relationship between the rs9939609 allele of fat mass and obesity-associated (FTO) gene and metabolic syndrome (MS) susceptibility has been evaluated by many studies, however, the results still remained controversial in the Chinese population. In order to provide more accurate results, we performed this meta-analysis.
METHODS: We searched PubMed, and Wanfang Med Online in both English and Chinese, and eight eligible studies comprising of 5345 cases and 9523 controls were eventually selected into our meta-analysis. The meta-analysis was performed using the STATA 12.0 software.
RESULTS: In pooled analysis, the FTO gene rs9939609 polymorphism significantly increased MS susceptibility under per-allele comparisons (A vs. T) (OR 1.21, 95% CI 1.10-1.35, P < 0.001) and in dominant model (OR 1.35, 95% CI 1.13-1.62, P < 0.001). Subgroup analyses under per-allele comparisons (A vs. T) indicated that the elevated risk was observed in adults (OR 1.26, 95% CI 1.08-1.47, P = 0.003) but not in children and adolescents (OR 1.14, 95% CI 0.95-1.36, P = 0.17), and that the risk for increasing MS was only identified in IDF groups (OR 1.22, 95% CI 1.03-1.43, P = 0.018) but not in NCEP ATP III groups (OR 1.14, 95% CI 0.95-1.36, P = 0.17); in both population-based (PB) and hospital-based (HB) groups, A alleles of rs9939609 appeared to be linked to increased MS susceptibilities (HB group: OR 1.51, 95% CI 1.10-2.08, P = 0.01; PB group: OR 1.19, 95% CI 1.09-1.30, P < 0.001). No significant association was established in dominant model subgroup analyses except PB group (OR 1.29, 95% CI 1.05-1.53, P < 0.001).
CONCLUSION: Our results suggested that the FTO gene rs9939609 polymorphism significantly increased MS susceptibility in Chinese. Our results should be verified by well-designed studies with larger sample size.

Entities:  

Keywords:  FTO gene; Meta-analysis; Metabolic syndrome; Polymorphism; rs9939609

Mesh:

Substances:

Year:  2020        PMID: 32303904     DOI: 10.1007/s12020-020-02280-x

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  32 in total

1.  The metabolic syndrome--a new worldwide definition.

Authors:  K George M M Alberti; Paul Zimmet; Jonathan Shaw
Journal:  Lancet       Date:  2005 Sep 24-30       Impact factor: 79.321

2.  Prevalence of metabolic syndrome is still underestimated in the Chinese population.

Authors:  Tsung O Cheng
Journal:  Int J Cardiol       Date:  2006-07-07       Impact factor: 4.164

3.  Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism.

Authors:  Julia Steinberger; Stephen R Daniels; Robert H Eckel; Laura Hayman; Robert H Lustig; Brian McCrindle; Michele L Mietus-Snyder
Journal:  Circulation       Date:  2009-01-12       Impact factor: 29.690

Review 4.  The investigations of genetic determinants of the metabolic syndrome.

Authors:  Behdokht Fathi Dizaji
Journal:  Diabetes Metab Syndr       Date:  2018-04-11

5.  The prevalence of microalbuminuria and its relationships with the components of metabolic syndrome in the general population of China.

Authors:  BaoDe Chen; DaGan Yang; Yu Chen; WeiYi Xu; Bo Ye; ZhenYuan Ni
Journal:  Clin Chim Acta       Date:  2010-02-04       Impact factor: 3.786

6.  Prevalence and correlates of the metabolic syndrome in a population-based sample of European youth.

Authors:  Ulf Ekelund; Sigmund Anderssen; Lars Bo Andersen; Chris J Riddoch; Luis B Sardinha; Jian'an Luan; Karsten Froberg; Soren Brage
Journal:  Am J Clin Nutr       Date:  2008-12-03       Impact factor: 7.045

7.  Prevalence and determinants of the metabolic syndrome among Tunisian adults: results of the Transition and Health Impact in North Africa (TAHINA) project.

Authors:  Hanen Belfki; Samir Ben Ali; Hajer Aounallah-Skhiri; Pierre Traissac; Souha Bougatef; Bernard Maire; Francis Delpeuch; Noureddine Achour; Habiba Ben Romdhane
Journal:  Public Health Nutr       Date:  2012-08-13       Impact factor: 4.022

Review 8.  Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications.

Authors:  Christopher P Cannon
Journal:  Am J Cardiol       Date:  2008-12-22       Impact factor: 2.778

9.  Prevalence of metabolic syndrome and factors associated with its components in Chinese adults.

Authors:  Hui Zuo; Zumin Shi; Xiaoshu Hu; Ming Wu; Zhirong Guo; Akhtar Hussain
Journal:  Metabolism       Date:  2009-06-18       Impact factor: 8.694

10.  Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome.

Authors:  Yanhua Wu; Yaqin Yu; Tiancheng Zhao; Shibin Wang; Yingli Fu; Yue Qi; Guang Yang; Wenwang Yao; Yingying Su; Yue Ma; Jieping Shi; Jing Jiang; Changgui Kou
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

View more
  3 in total

1.  -308G/A polymorphism of tumor necrosis factor alpha (TNF-α) gene and metabolic syndrome susceptibility: a meta-analysis.

Authors:  Dong Wang; Liqun He; Xiaotian Zhang
Journal:  Sci Rep       Date:  2021-02-15       Impact factor: 4.379

Review 2.  Natural Aporphine Alkaloids with Potential to Impact Metabolic Syndrome.

Authors:  Fei-Xuan Wang; Nan Zhu; Fan Zhou; Dong-Xiang Lin
Journal:  Molecules       Date:  2021-10-10       Impact factor: 4.411

3.  Association between the FTO SNP rs9939609 and Metabolic Syndrome in Chilean Children.

Authors:  Rafael Molina-Luque; Natalia Ulloa; Manuel Romero-Saldaña; Martin Zilic; Andrea Gleisner; Fabián Lanuza; Guillermo Molina-Recio
Journal:  Nutrients       Date:  2021-06-11       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.